Thus, targeting STEAP1 and SP-NK1R signaling pathways, along with addressing ferroptosis, may provide therapeutic benefits in mitigating sepsis-induced ALI by reducing ferroptosis and associated inflammation. Here, TFF2 is linked to Sepsis.